CHRISTINE HARRIS: Open Payments
NPI 1497725733 · GIG HARBOR, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 40 payments from 18 companies in 2025. Trend: 2023 $154 · 2024 $495 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $170 |
| Corcept Therapeutics | 4 | $130 |
| Novo Nordisk Inc | 3 | $62 |
| Lilly USA, LLC | 3 | $50 |
| PFIZER INC. | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Insulet Corporation | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
Products named: Korlym, QULIPTA, UBRELVY, Wegovy, MOUNJARO, Kerendia, Omnipod, CAPVAXIVE.
Industry payments across WA — which companies pay providers there.
